Americans Back Medical Psychedelics Research, Survey Finds

A remarkable shift in public opinion is opening doors for psychedelic medicine research that could help millions struggling with mental health conditions.

A new survey from UC Berkeley found that 63% of U.S. voters strongly support lowering barriers to study psychedelics like psilocybin and MDMA. That's a significant jump from just 49% in 2023, suggesting Americans are increasingly willing to explore these substances as potential treatments.

The poll surveyed over 1,500 voters in April 2025 and revealed other encouraging trends. Support for legalizing therapeutic use rose from 36% to 46%, while backing for prescription access climbed from 29% to 41%.

Interestingly, support for full decriminalization remained steady at around 28%. This suggests people want careful, medically supervised approaches rather than wholesale policy changes.

"People are being flooded with information about psychedelics," says Tyrone Sgambati, a postdoctoral research scientist who co-authored the report. He believes this growing awareness is sparking genuine curiosity about potential benefits.

The Ripple Effect

This shift in public opinion could accelerate breakthrough treatments for conditions that have resisted conventional therapies. Early research suggests psilocybin may help with treatment-resistant depression, while MDMA shows promise for PTSD.

Mason Marks, a senior fellow at Harvard Law School's Project on Psychedelics Law and Regulation, sees the findings as evidence of "increasing public acceptance" of psychedelic treatments. More research could help scientists understand exactly how and why these substances might work therapeutically.

The timing aligns with policy changes too. In April, President Trump signed an executive order aimed at boosting psychedelic therapy research, which experts say could lower barriers to studying these compounds.

While psychedelics like LSD, MDMA, and psilocybin remain federally illegal to possess, the regulatory landscape for research appears to be shifting. The survey suggests voters are ready for science to catch up with their growing openness.

This evolving public consensus could pave the way for treatments that transform mental healthcare for generations to come.